Navigation Links
Bionovo Announces Third Quarter 2010 Highlights and Financial Results
Date:11/11/2010

ating expenses:Research and development

3,6732,93810,8079,49350,513General and administrative

9879262,6273,11020,229Merger cost

----1,964Total operating expenses

4,6603,86413,43412,60372,706Loss from operations

(4,592)(3,709)(13,352)(12,441)(71,444)Change in fair value of warrant liability

----831Interest income

2516752,090Interest expense

(9)(22)(33)(77)(493)Other expense

(28)-(39)(86)(206)Net loss

$
(4,627)$
(3,726)$  (13,408)$  (12,529)$
(69,222)Basic and diluted net loss per common share

$
(0.21)$
(0.24)$
(0.62)$
(0.82)$
(6.58)Shares used in computing basic and diluted
net loss per share

21,78515,28721,60715,27810,517Bionovo, Inc.(A Development Stage Company)Consolidated Balance Sheets(in thousands, except share amounts)September 30,
2010December 31,
2009(unaudited)ASSETSCurrent assets:Cash and cash equivalents

$
3,113$
2,799Short-term investments

-13,135Receivables

69251Prepaid expenses

1,133214Other current assets

232161Total current assets

4,54716,560Property and equipment, net

7,1216,197Patent pending, net

1,187822Other assets

1,184570Total assets

$
4,039$
24,149LIABILITIES AND SHAREHOLDERS’ EQUITYCurrent liabilities:Accounts payable

$
386$
311Accrued compensation and benefits

344367Current portion of capital lease obligations

1,123476Current portion of notes payable

5459Other current liabilities

1,194823Total current liabilities

3,1012,036Non-current portion of capital lease obligations

1,01996Non-current portion of notes payable

83121Total liabilities

4,2032,253Commitments and contingenciesShareholders’ equity:Preferred stock, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding

--Common stock $0.0001 par value, 68,000,000 sha
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2010 Financial Results on Thursday, November 11, 2010
2. Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions
3. Bionovo to Raise $3 Million Through Registered Direct Offering
4. Bionovo to Present at the JMP Securities Healthcare Conference
5. Bionovo to Present at Cambria Capital Investor Meeting
6. Bionovo Receives Positive Guidance from FDA on Menerba®
7. Bionovo Announces Reverse Stock Split
8. Bionovo Announces Publication Describing Menerbas Effect on Neural Pathways Related to Temperature Regulation
9. Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe
10. Bionovo, Inc. to Announce Second Quarter Fiscal Year 2010 Financial Results on Wednesday, August 4, 2010
11. Bionovo Announces a $15 Million At-The-Market Firm Commitment Financing Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  A recently published ... Houston, Texas , demonstrates that 3D ... increasing cancer detection. The study, "Implementation ... Observational Study," was led by Stephen L. ... issue of the American Journal of Roentgenology ...
(Date:5/23/2013)... 23, 2013  The need to add tissue ... was highlighted prominently at the 108 th ... in San Diego.  According to SonaCare Medical, a ... (HIFU) technology, the need for image-guided technologies to ... to consider minimally invasive ablative treatments, was addressed ...
(Date:5/23/2013)...  Hologic, Inc. (Hologic or the Company) (NASDAQ: ... and supplier of premium diagnostics, medical imaging systems ... the healthcare needs of women, today announced that ... clinical practice comparing breast cancer screening with Hologic,s ... mammography alone showed a significant reduction in recall ...
Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
... in Psychiatry , , HARTFORD, Conn., ... current issue of the Future Medicine Group (London) journal ... are helping to point the way toward the application of DNA-guided ... The Institute of Living of Hartford Hospital in collaboration with Genomas. ...
... The Takeda Oncology Company today reported updated results ... the large, international Phase III VISTA(1) trial showing ... multiple myeloma given VELCADE, melphalan and prednisone (VcMP). ... patient sub-groups, including those with poor prognostic characteristics, ...
Cached Medicine Technology:Genomas Clinical Study Finds Increased Prevalence of Drug Metabolism Deficiencies in Patients With Serious Psychotropic Side Effects 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 4Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 5Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 6
(Date:5/24/2013)... Atlanta, GA (PRWEB) May 24, 2013 Started ... convention held in Orlando. 2013 marks AMTC’s 31st anniversary. ... same family, starting with supermodel Millie Lewis and her daughter, ... by top agents, managers, casting directors, and music professionals including ... Dramatic Arts and XP Media. They are kings of Hollywood ...
(Date:5/24/2013)... failed to replicate what appeared to be breakthrough results ... were published last year in the journal Science ... suggested that the drug bexarotene (marketed as Targretin) could ... a pathological hallmark of Alzheimer,s disease in ... the 2012 report, drug treatment quickly removed most of ...
(Date:5/24/2013)... City, Utah (PRWEB) May 24, 2013 ... , with exciting new enhancements for instructors and students. ... stay more focused through personalize learning plan templates, targeted ... AnatomyOne release provides 500 new assessment questions, 5,000 searchable ... review notes. , AnatomyOne 2.0 is the ...
(Date:5/24/2013)... Los Angeles, CA (PRWEB) May 24, 2013 ... is to present the 3rd Annual EB-5 Investment Summit: ... 2013. The Dealmakers Conference will focus on exploring alternative ... provide the latest market, legal and economic information, and ... legal professionals within the EB-5 industry. , "Our ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Dwell ... VP, Brandon Huff as Executive Vice President of Digital ... business units, which represented a large portion of Yahoo's ... growth as Dwell develops a fully-integrated commerce unit to ... of experience monetizing digital content for leading firms in ...
Breaking Medicine News(10 mins):Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2
... system for measuring brain tissue with magnetic resonance imaging ... at an earlier stage according to a new study ... Radiology . , In Alzheimer,s disease, nerve cell death ... especially the hippocampus region, to shrink. MRI with high ...
... XM 157 on XM Satellite Radio,and The United ... of a new 13 week programming series designed ... clinical trauma, internal,medicine, medical education and much more., ... and educate medical,professionals and those interested in a ...
... 23 Colonial Life & Accident,Insurance Company has set up dedicated ... in the Midwest to get support from the,company., (Logo: ... centers toll free at these,numbers:, Policyholders: ... Brokers: ...
... They resulted in 8,000 deaths, 56,000 hospitalizations for those ... June 23 (HealthDay News) -- In 2005, traumatic brain ... deaths and 56,000 hospitalizations among Americans age 65 and ... and Prevention study. , TBIs accounted for ...
... Medical Association Provides Tips on Caring for Your ... ... teenagers,love horses and often parents buy or lease a horse for their ... of a horse can be wonderful but a,time-consuming responsibility," said Dr. Jeff ...
... prohibitive, experts say , , MONDAY, June 23 (HealthDay News) -- ... overall death risk for American adults, a new study suggests. ... of who will have a problem and who will not," ... at the Harbor-UCLA Medical Center. , He and his colleagues ...
Cached Medicine News:Health News:Automated MRI technique assists in earlier Alzheimer's diagnosis 2Health News:The United States Army Medical Department Announces the Launch of an Innovative New Programming Series Called 'The Strength to Heal' That Will Run on ReachMD XM 157 - The Channel for Medical Professionals on XM Radio. 2Health News:The United States Army Medical Department Announces the Launch of an Innovative New Programming Series Called 'The Strength to Heal' That Will Run on ReachMD XM 157 - The Channel for Medical Professionals on XM Radio. 3Health News:Support Numbers for Colonial Life & Accident Insurance Company Customers Affected by Floods 2Health News: Senior Falls Can Lead to Brain Injury 2Health News:Saddle Up! Getting a Jump on Proper Horse Care 2Health News:Arterial Calcium Scans Can Predict Death Risk 2Health News:Arterial Calcium Scans Can Predict Death Risk 3Health News:Arterial Calcium Scans Can Predict Death Risk 4
... V is a low viscosity bone cement, ... vertebroplasty. The bone cement is injected into ... Osteopal V is used for the augmentation ... zirconium dioxide is included in the cement ...
... to fuse multiple image sets in seconds, ... treatment planning and follow-up. ImageFusion aligns images ... features of different scan types. Radionics supports ... clinicians can capitalize on the unique strengths ...
... The Framelink Stereotactic Linking System simplifies ... Brain Stimulation (DBS). This software integrates ... and microelectrode recording data, to assist in ... deep brain target location. Framelink interfaces ...
It provides cranial support in either supine or semi-sitting procedures....
Medicine Products: